Ligand Plans $550M Convertible Notes Due 2031 With $75M Repurchase Program
LGND•Ligand plans to issue $550 million convertible senior notes due September 15, 2031, with an option for an additional $82.5 million and semiannual interest starting March 2027. It will use up to $75 million for share repurchases and note hedge transactions to offset dilution on conversion.
1. Offering Details
Ligand intends to conduct a private placement of $550 million aggregate principal amount of convertible senior notes due September 15, 2031, with a 13-day option for an additional $82.5 million. The notes will be general unsecured senior obligations with interest payable semiannually beginning March 15, 2027, and will be convertible or redeemable prior to maturity under specified conditions.
2. Use of Proceeds
Net proceeds will fund convertible hedge transactions and privately negotiated share repurchases of up to $75 million to mitigate potential dilution upon conversion. Remaining proceeds are earmarked for general corporate purposes, including investments in complementary businesses and technologies, with no binding commitments beyond a prior royalty acquisition agreement.
3. Hedge and Warrant Transactions
Concurrent hedge and warrant transactions will accompany the note issuance, aiming to offset cash payments or dilution from future conversions. Ligand will enter convertible note hedges and issue warrants to counterparties, whose derivative activities in the stock could influence Ligand’s share price before and after pricing.
4. Market and Conversion Impact
Option counterparties and affiliates may adjust hedge positions by trading derivatives or shares of common stock, potentially causing volatility in Ligand’s share price or note value. Such market activity could affect conversion ratios, the number of shares delivered, and the effective cost of conversions for note holders.
